InvestorsHub Logo
Followers 3
Posts 584
Boards Moderated 0
Alias Born 12/16/2015

Re: BioInvestor4 post# 81238

Monday, 02/26/2018 9:20:31 AM

Monday, February 26, 2018 9:20:31 AM

Post# of 144813
Nothing regarding Phase 2B, where's the Glitch in the system?

A planned PR for cell bank completion, but nothing for changing from Pivotal to Phase 2b.

Why?

Was it deliberately hidden? There is no way, that out there is a PR lost somewhere in cyberspace, that was supposed to inform everyone that we are now switching from Pivotal to Phase 2b.

Nothing. I'm a strong long here, but this looks very, very bad imo.

"PharmaCyte is working on an IND to submit to the FDA so that it can begin a clinical trial involving locally advanced, inoperable, non-metastatic pancreatic cancer and expects to submit its IND later this year. "

I told you so. Best bet is end of the year. Not end of Q1, maybe in the summer, but looking like Sept.-Nov.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News